Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 4680732, 14 pages
https://doi.org/10.1155/2017/4680732
Review Article

The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain

1Departamento de Biología y Toxicología de la Reproducción, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, 72000 Heroica Puebla de Zaragoza, PUE, Mexico
2Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 70228 Mexico City, Mexico
3Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, 14269 Mexico City, Mexico
4Departamento de Investigación en Bioquímica, Instituto Nacional de Enfermedades Respiratorias, 14080 Mexico City, Mexico
5Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México, 04510 Mexico City, Mexico

Correspondence should be addressed to D. Silva-Adaya

Received 15 September 2016; Revised 24 November 2016; Accepted 29 November 2016; Published 10 January 2017

Academic Editor: Francisco J. Romero

Copyright © 2017 W. A. García-Suástegui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. S. Goodman, A. Gilman, and L. L. Brunton, Goodman & Gilman's Manual of Pharmacology and Therapeutics, McGraw-Hill Medical, New York, NY, USA, 2008.
  2. H. E. Lowndes, C. M. Beiswanger, M. A. Philbert, and K. R. Reuhl, “Substrates for neural metabolism of xenobiotics in adult and developing brain,” NeuroToxicology, vol. 15, no. 1, pp. 61–73, 1994. View at Google Scholar · View at Scopus
  3. E. A. Hodgson, Textbook of Modern Toxicology, John Wiley & Sons, 3rd edition, 2004.
  4. S.-F. Zhou, J.-P. Liu, and B. Chowbay, “Polymorphism of human cytochrome P450 enzymes and its clinical impact,” Drug Metabolism Reviews, vol. 41, no. 2, pp. 89–295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Hodgson and P. E. Levi, Introduction to Biochemical Toxicology, Appleton & Lange, Norwalk, Conn, USA, 2nd edition, 1994.
  6. E. M. Isin and F. P. Guengerich, “Complex reactions catalyzed by cytochrome P450 enzymes,” Biochimica et Biophysica Acta (BBA)—General Subjects, vol. 1770, no. 3, pp. 314–329, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. L. Miksys and R. F. Tyndale, “Drug-metabolizing cytochrome P450s in the brain,” Journal of Psychiatry & Neuroscience, vol. 27, no. 6, pp. 406–415, 2002. View at Google Scholar · View at Scopus
  8. B. Walther, J. F. Ghersi-Egea, A. Minn, and G. Siest, “Subcellular distribution of cytochrome P-450 in the brain,” Brain Research, vol. 375, no. 2, pp. 338–344, 1986. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Warner, H. Hellmold, S. Yoshida, D. Liao, E. Hedlund, and J.-Å. Gustafsson, “Cytochrome P450 in the breast and brain: role in tissue-specific activation of xenobiotics,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 376, no. 1-2, pp. 79–85, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. R. L. Haining and M. Nichols-Haining, “Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action?” Pharmacology & Therapeutics, vol. 113, no. 3, pp. 537–545, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. L. A. Howard, S. Miksys, E. Hoffmann, D. Mash, and R. F. Tyndale, “Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics,” British Journal of Pharmacology, vol. 138, no. 7, pp. 1376–1386, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. S. V. Bhagwat, M. R. Boyd, and V. Ravindranath, “Brain mitochondrial cytochromes P450: xenobiotic metabolism, presence of multiple forms and their selective inducibility,” Archives of Biochemistry and Biophysics, vol. 320, no. 1, pp. 73–83, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Montoliu, M. Sancho-Tello, I. Azorin et al., “Ethanol increases cytochrome P4502E1 and induces oxidative stress in astrocytes,” Journal of Neurochemistry, vol. 65, no. 6, pp. 2561–2570, 1995. View at Google Scholar · View at Scopus
  14. M. Seliskar and D. Rozman, “Mammalian cytochromes P450—importance of tissue specificity,” Biochimica et Biophysica Acta—General Subjects, vol. 1770, no. 3, pp. 458–466, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Knockaert, B. Fromenty, and M.-A. Robin, “Mechanisms of mitochondrial targeting of cytochrome P450 2E1: physiopathological role in liver injury and obesity,” The FEBS Journal, vol. 278, no. 22, pp. 4252–4260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C. S. Ferguson and R. F. Tyndale, “Cytochrome P450 enzymes in the brain: emerging evidence of biological significance,” Trends in Pharmacological Sciences, vol. 32, no. 12, pp. 708–714, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Dutheil, S. Dauchy, M. Diry et al., “Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function,” Drug Metabolism & Disposition, vol. 37, no. 7, pp. 1528–1538, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Anzenbacher and E. Anzenbacherová, “Cytochromes P450 and metabolism of xenobiotics,” Cellular and Molecular Life Sciences, vol. 58, no. 5-6, pp. 737–747, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. M. C. E. McFadyen, W. T. Melvin, and G. I. Murray, “Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain,” Biochemical Pharmacology, vol. 55, no. 6, pp. 825–830, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. G. I. Murray, S. Pritchard, W. T. Melvin, and M. D. Burke, “Cytochrome P450 CYP3A5 in the human anterior pituitary gland,” FEBS Letters, vol. 364, no. 1, pp. 79–82, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. C. R. M. Rieder, D. B. Ramsden, and A. C. Williams, “Cytochrome P450 1B1 mRNA in the human central nervous system,” Molecular Pathology, vol. 51, no. 3, pp. 138–142, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. J. A. G. Agúndez, F. J. Jiménez-Jiménez, H. Alonso-Navarro, and E. García-Martín, “Drug and xenobiotic biotransformation in the blood-brain barrier: a neglected issue,” Frontiers in Cellular Neuroscience, vol. 8, article 335, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Dauchy, F. Dutheil, R. J. Weaver et al., “ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier,” Journal of Neurochemistry, vol. 107, no. 6, pp. 1518–1528, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. R. P. Meyer, M. Gehlhaus, R. Knoth, and B. Volk, “Expression and function of cytochrome P450 in brain drug metabolism,” Current Drug Metabolism, vol. 8, no. 4, pp. 297–306, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Schilter, M. R. Andersen, C. Acharya, and C. J. Omiecinski, “Activation of cytochrome P450 gene expression in the rat brain by phenobarbital-like inducers,” Journal of Pharmacology and Experimental Therapeutics, vol. 294, no. 3, pp. 916–922, 2000. View at Google Scholar · View at Scopus
  26. C. S. Lieber, “Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968–1998)—a review,” Alcoholism: Clinical and Experimental Research, vol. 23, no. 6, pp. 991–1007, 1999. View at Google Scholar · View at Scopus
  27. C. S. Ferguson, S. Miksys, R. Palmour, and R. F. Tyndale, “Independent and combined effects of ethanol self-administration and nicotine treatment on hepatic CYP2E1 in African green monkeys,” Drug Metabolism & Disposition, vol. 39, no. 12, pp. 2233–2241, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Boussadia, C. Ghosh, C. Plaud et al., “Effect of status epilepticus and antiepileptic drugs on CYP2E1 brain expression,” Neuroscience, vol. 281, pp. 124–134, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Toselli, I. M. Booth Depaz, S. Worrall et al., “Expression of CYP2E1 and CYP2U1 proteins in amygdala and prefrontal cortex: influence of alcoholism and smoking,” Alcoholism: Clinical & Experimental Research, vol. 39, no. 5, pp. 790–797, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Nosti-Palacios, J. Gómez-Garduño, D. Molina-Ortiz, R. Calzada-León, V. M. Dorado-González, and A. Vences-Mejía, “Aspartame administration and insulin treatment altered brain levels of CYP2E1 and CYP3A2 in streptozotocin-induced diabetic rats,” International Journal of Toxicology, vol. 33, no. 4, pp. 325–331, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Zakhari, “Overview: how is alcohol metabolized by the body?” Alcohol Research & Health, vol. 29, no. 4, pp. 245–254, 2006. View at Google Scholar · View at Scopus
  32. J. G. Restrepo, E. Garcia-Martín, C. Martínez, and J. A. G. Agúndez, “Polymorphic drug metabolism in anaesthesia,” Current Drug Metabolism, vol. 10, no. 3, pp. 236–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Martínez, S. Galván, E. Garcia-Martin, M. I. Ramos, Y. Gutiérrez-Martín, and J. A. G. Agúndez, “Variability in ethanol biodisposition in whites is modulated by polymorphisms in the ADH1B and ADH1C genes,” Hepatology, vol. 51, no. 2, pp. 491–500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. C. S. Lieber, “The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role,” Drug Metabolism Reviews, vol. 36, no. 3-4, pp. 511–529, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Ji, “Mechanisms of alcohol-induced endoplasmic reticulum stress and organ injuries,” Biochemistry Research International, vol. 2012, Article ID 216450, 12 pages, 2012. View at Publisher · View at Google Scholar
  36. E. P. A. Neve and M. J. Ingelman-Sundberg, “Molecular basis for the transport of cytochrome P450 2E1 to the plasma membrane,” The Journal of Biological Chemistry, vol. 275, no. 22, pp. 17130–17135, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. P. G. Zaphiropoulos and T. Wood, “Identification of the major cytochrome P450S of subfamily 2C that are expressed in brain of female rats and in olfactory lobes of ethanol treated male rats,” Biochemical and Biophysical Research Communications, vol. 193, no. 3, pp. 1006–1013, 1993. View at Publisher · View at Google Scholar · View at Scopus
  38. B. J. Roberts, S. E. Shoaf, K. S. Jeong, and B. J. Song, “Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration and withdrawal: evidence that CYP2E1 possesses a rapid phase half-life of 6 hours or less,” Biochemical and Biophysical Research Communications, vol. 205, no. 2, pp. 1064–1071, 1994. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Warner and J.-Å. Gustafsson, “Effect of ethanol on cytochrome P450 in the rat brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 3, pp. 1019–1023, 1994. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Tindberg and M. Ingelman-Sundberg, “Expression, catalytic activity, and inducibility of cytochrome P450 2E1 (CYP2E1) in the rat central nervous system,” Journal of Neurochemistry, vol. 67, no. 5, pp. 2066–2073, 1996. View at Google Scholar · View at Scopus
  41. S. C. Upadhya, P. S. Tirumalai, M. R. Boyd, T. Mori, and V. Ravindranath, “Cytochrome P4502E (CYP2E) in brain: constitutive expression, induction by ethanol and localization by fluorescence in situ hybridization,” Archives of Biochemistry and Biophysics, vol. 373, no. 1, pp. 23–34, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. H. K. Anandatheerthavarada, S. K. Shankar, S. Bhamre, M. R. Boyd, B.-J. Song, and V. Ravindranath, “Induction of brain cytochrome P-450IIE1 by chronic ethanol treatmen,” Brain Research, vol. 601, no. 1-2, pp. 279–285, 1993. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Hansson, N. Tindberg, M. Ingelman-Sundberg, and C. Köhler, “Regional distribution of ethanol-inducible cytochrome P450 IIE1 in the rat central nervous system,” Neuroscience, vol. 34, no. 2, pp. 451–463, 1990. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Joshi and R. F. Tyndale, “Induction and recovery time course of rat brain CYP2E1 after nicotine treatment,” Drug Metabolism and Disposition, vol. 34, no. 4, pp. 647–652, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. J.-Y. Wu, J. Yue, and Y.-Q. Feng, “Determination of brain cytochrome P450 2E1 activity in rat with the probe of chlorzoxazone by liquid chromatography-mass spectrometry,” Journal of Chromatography B, vol. 879, no. 3-4, pp. 260–266, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Yadav, A. Dhawan, R. L. Singh, P. K. Seth, and D. Parmar, “Expression of constitutive and inducible cytochrome P450 2E1 in rat brain,” Molecular and Cellular Biochemistry, vol. 286, no. 1-2, pp. 171–180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Haorah, B. Knipe, J. Leibhart, A. Ghorpade, and Y. Persidsky, “Alcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunction,” Journal of Leukocyte Biology, vol. 78, no. 6, pp. 1223–1232, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. F. M. Farin and C. J. Omiecinski, “Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue,” Journal of Toxicology and Environmental Health, vol. 40, no. 2-3, pp. 317–335, 1993. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Joshi and R. F. Tyndale, “Regional and cellular distribution of CYP2E1 in monkey brain and its induction by chronic nicotine,” Neuropharmacology, vol. 50, no. 5, pp. 568–575, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Martinez-Gil, M. Flores-Bellver, S. Atienzar-Aroca et al., “CYP2E1 in the human retinal pigment epithelium: expression, activity, and induction by ethanol,” Investigative Ophthalmology & Visual Science, vol. 56, no. 11, pp. 6855–6863, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Boutelet-Bochan, Y. Huang, and M. R. Juchau, “Expression of CYP2E1 during embryogenesis and fetogenesis in human cephalic tissues: implications for the fetal alcohol syndrome,” Biochemical and Biophysical Research Communications, vol. 238, no. 2, pp. 443–447, 1997. View at Publisher · View at Google Scholar · View at Scopus
  52. M. R. Brzezinski, H. Boutelet-Bochan, R. E. Person, A. G. Fantel, and M. R. Juchau, “Catalytic activity and quantitation of cytochrome P-450 2E1 in prenatal human brain,” Journal of Pharmacology and Experimental Therapeutics, vol. 289, no. 3, pp. 1648–1653, 1999. View at Google Scholar · View at Scopus
  53. N. Kapoor, A. B. Pant, A. Dhawan et al., “Differences in sensitivity of cultured rat brain neuronal and glial cytochrome P450 2E1 to ethanol,” Life Sciences, vol. 79, no. 16, pp. 1514–1522, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. B.-J. Song, H. V. Gelboin, S.-S. Park, C. S. Yang, and F. J. Gonzalez, “Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme,” The Journal of Biological Chemistry, vol. 261, no. 35, pp. 16689–16697, 1986. View at Google Scholar · View at Scopus
  55. C. S. Yang, J.-S. H. Yoo, H. Ishizaki, and J. Hong, “Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation,” Drug Metabolism Reviews, vol. 22, no. 2-3, pp. 147–159, 1990. View at Publisher · View at Google Scholar · View at Scopus
  56. F. P. Guengerich, D.-H. Kim, and M. Iwasaki, “Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects,” Chemical Research in Toxicology, vol. 4, no. 2, pp. 168–179, 1991. View at Publisher · View at Google Scholar · View at Scopus
  57. C. S. Lieber, “Cytochrome P-4502E1: its physiological and pathological role,” Physiological Reviews, vol. 77, no. 2, pp. 517–544, 1997. View at Google Scholar · View at Scopus
  58. A. A. Caro and A. I. Cederbaum, “Oxidative stress, toxicology, and pharmacology of CYP2E1,” Annual Review of Pharmacology and Toxicology, vol. 44, pp. 27–42, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Kiselevski, N. Oganesian, S. Zimatkin et al., “Acetate metabolism in brain mechanisms of adaptation to ethanol,” Medical Science Monitor, vol. 9, no. 5, pp. 178–182, 2003. View at Google Scholar · View at Scopus
  60. Y. Zhong, G. Dong, H. Luo et al., “Induction of brain CYP2E1 by chronic ethanol treatment and related oxidative stress in hippocampus, cerebellum, and brainstem,” Toxicology, vol. 302, no. 2-3, pp. 275–284, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. L. A. Howard, J. S. Ahluwalia, S. Lin, E. M. Sellers, and R. F. Tyndale, “CYP2E11D regulatory polymorphism,” Pharmacogenetics, vol. 13, no. 6, pp. 321–328, 2003. View at Publisher · View at Google Scholar
  62. D. Lucas, C. Menez, C. Girre et al., “Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects,” Pharmacogenetics, vol. 5, no. 5, pp. 298–304, 1995. View at Publisher · View at Google Scholar · View at Scopus
  63. P.-H. Villard, E. M. Seree, J.-L. Re et al., “Effects of tobacco smoke on the gene expression of the Cyp1a, Cyp2b, Cyp2e, and Cyp3a subfamilies in mouse liver and lung: relation to single strand breaks of DNA,” Toxicology and Applied Pharmacology, vol. 148, no. 2, pp. 195–204, 1998. View at Publisher · View at Google Scholar · View at Scopus
  64. P. Batel, F. Pessione, C. Maitre, and B. Rueff, “Relationship between alcohol and tobacco dependencies among alcoholics who smoke,” Addiction, vol. 90, no. 7, pp. 977–980, 1995. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Ericson, J. A. Engel, and B. Söderpalm, “Peripheral involvement in nicotine-induced enhancement of ethanol intake,” Alcohol, vol. 21, no. 1, pp. 37–47, 2000. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Yue, J. Khokhar, S. Miksys, and R. F. Tyndale, “Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake,” European Journal of Pharmacology, vol. 609, no. 1–3, pp. 88–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. C. S. Ferguson, S. Miksys, R. M. Palmour, and R. F. Tyndale, “Ethanol self-administration and nicotine treatment induce brain levels of CYP2B6 and CYP2E1 in African green monkeys,” Neuropharmacology, vol. 72, pp. 74–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. F. Toselli, I. De Waziers, M. Dutheil et al., “Gene expression profiling of cytochromes P450, ABC transporters and their principal transcription factors in the amygdala and prefrontal cortex of alcoholics, smokers and drug-free controls by qRT-PCR,” Xenobiotica, vol. 45, no. 12, pp. 1129–1137, 2015. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Ze, R. Hu, X. Wang et al., “Neurotoxicity and gene-expressed profile in brain-injured mice caused by exposure to titanium dioxide nanoparticles,” Journal of Biomedical Materials Research Part A, vol. 102, no. 2, pp. 470–478, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Lavandera, S. Ruspini, A. Batlle, and A. M. Buzaleh, “Cytochrome P450 expression in mouse brain: specific isoenzymes involved in Phase i metabolizing system of porphyrinogenic agents in both microsomes and mitochondria,” Biochemistry and Cell Biology, vol. 93, no. 1, pp. 102–107, 2015. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Raza, S. K. Prabu, M.-A. Robin, and N. G. Avadhani, “Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress,” Diabetes, vol. 53, no. 1, pp. 185–194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. L. Knockaert, V. Descatoire, N. Vadrot, B. Fromenty, and M.-A. Robin, “Mitochondrial CYP2E1 is sufficient to mediate oxidative stress and cytotoxicity induced by ethanol and acetaminophen,” Toxicology In Vitro, vol. 25, no. 2, pp. 475–484, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. A. M. Lee, M. Joshi, J. Yue, and R. F. Tyndale, “Phenobarbital induces monkey brain CYP2E1 protein but not hepatic CYP2E1, in vitro or in vivo chlorzoxazone metabolism,” European Journal of Pharmacology, vol. 552, no. 1–3, pp. 151–158, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Johri, S. Yadav, A. Dhawan, and D. Parmar, “Overexpression of cerebral and hepatic cytochrome P450s alters behavioral activity of rat offspring following prenatal exposure to lindane,” Toxicology and Applied Pharmacology, vol. 225, no. 3, pp. 278–292, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Vences-Mejía, J. Gómez-Garduño, H. Caballero-Ortega et al., “Effect of mosquito mats (pyrethroid-based) vapor inhalation on rat brain cytochrome P450s,” Toxicology Mechanisms and Methods, vol. 22, no. 1, pp. 41–46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  76. G. Eraslan, M. Kanbur, Y. Siliğ, M. Karabacak, Z. Soyer Sarlca, and S. Şahin, “The acute and chronic toxic effect of cypermethrin, propetamphos, and their combinations in rats,” Environmental Toxicology, vol. 31, no. 11, pp. 1415–1429, 2016. View at Publisher · View at Google Scholar · View at Scopus
  77. A. C. Valencia-Olvera, J. Morán, R. Camacho-Carranza, O. Prospéro-García, and J. J. Espinosa-Aguirre, “CYP2E1 induction leads to oxidative stress and cytotoxicity in glutathione-depleted cerebellar granule neurons,” Toxicology in Vitro, vol. 28, no. 7, pp. 1206–1214, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. D. Abdulla, K. B. Goralski, and K. W. Renton, “The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat,” Toxicology and Applied Pharmacology, vol. 216, no. 1, pp. 1–10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. P. Kelicen and N. Tindberg, “Lipopolysaccharide induces CYP2E1 in astrocytes through MAP kinase kinase-3 and C/EBP/β and -δ,” Journal of Biological Chemistry, vol. 279, no. 16, pp. 15734–15742, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Birnie, R. Morrison, R. Camara, and K. I. Strauss, “Temporal changes of cytochrome P450 (Cyp) and eicosanoid-related gene expression in the rat brain after traumatic brain injury,” BMC Genomics, vol. 14, no. 1, article 303, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. N. Tindberg, H. A. Baldwin, A. J. Cross, and M. Ingelman-Sundberg, “Induction of cytochrome P450 2E1 expression in rat and gerbil astrocytes by inflammatory factors and ischemic injury,” Molecular Pharmacology, vol. 50, no. 5, pp. 1065–1072, 1996. View at Google Scholar · View at Scopus
  82. C. Hao, W. Liu, X. Luan et al., “Aquaporin-4 knockout enhances astrocyte toxicity induced by 1-methyl-4-phenylpyridinium ion and lipopolysaccharide via increasing the expression of cytochrome P4502E1,” Toxicology Letters, vol. 198, no. 2, pp. 225–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. R. F. Novak and K. J. Woodcroft, “The alcohol-inducible form of cytochrome P450 (CYP 2E1): role in toxicology and regulation of expression,” Archives of Pharmacal Research, vol. 23, no. 4, pp. 267–282, 2000. View at Publisher · View at Google Scholar · View at Scopus
  84. B. J. Song, T. Matsunaga, J. P. Hardwick et al., “Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat,” Molecular Endocrinology, vol. 1, no. 8, pp. 542–547, 1987. View at Publisher · View at Google Scholar · View at Scopus
  85. B. J. Roberts, B.-J. Song, Y. Soh, S. S. Park, and S. E. Shoaf, “Ethanol induces CYP2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of CYP2E1,” The Journal of Biological Chemistry, vol. 270, no. 50, pp. 29632–29635, 1995. View at Publisher · View at Google Scholar · View at Scopus
  86. T. Mohri, M. Nakajima, T. Fukami, M. Takamiya, Y. Aoki, and T. Yokoi, “Human CYP2E1 is regulated by miR-378,” Biochemical Pharmacology, vol. 79, no. 7, pp. 1045–1052, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. L. Miao, H. Yao, C. Li et al., “A dual inhibition: microRNA-552 suppresses both transcription and translation of cytochrome P450 2E1,” Biochimica et Biophysica Acta, vol. 1859, no. 4, pp. 650–662, 2016. View at Publisher · View at Google Scholar
  88. J. Limón-Pacheco and M. E. Gonsebatt, “The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 674, no. 1-2, pp. 137–147, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Valdovinos-Flores and M. E. Gonsebatt, “The role of amino acid transporters in GSH synthesis in the blood-brain barrier and central nervous system,” Neurochemistry International, vol. 61, no. 3, pp. 405–414, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. E. Birben, U. M. Sahiner, C. Sackesen, S. Erzurum, and O. Kalayci, “Oxidative stress and antioxidant defense,” World Allergy Organization Journal, vol. 5, no. 1, pp. 9–19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. D. Silva-Adaya, M. E. Gonsebatt, and J. Guevara, “Thioredoxin system regulation in the central nervous system: experimental models and clinical evidence,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 590808, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  92. L. C. Bell and F. P. Guengerich, “Oxidation kinetics of ethanol by human cytochrome P450 2E1. Rate- limiting product release accounts for effects of isotopic hydrogen substitution and cytochrome b5 on steady-state kinetics,” Journal of Biological Chemistry, vol. 272, no. 47, pp. 29643–29651, 1997. View at Publisher · View at Google Scholar · View at Scopus
  93. X.-L. Cao, J. Du, Y. Zhang, J.-T. Yan, and X.-M. Hu, “Hyperlipidemia exacerbates cerebral injury through oxidative stress, inflammation and neuronal apoptosis in MCAO/reperfusion rats,” Experimental Brain Research, vol. 233, no. 10, pp. 2753–2765, 2015. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Liu, Y. Xu, X. Han et al., “Potent effects of flavonoid-rich extract from Rosa laevigata Michx fruit against hydrogen peroxide-induced damage in PC12 cells via attenuation of oxidative stress, inflammation and apoptosis,” Molecules, vol. 19, no. 8, pp. 11816–11832, 2014. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Jin, A. Ande, A. Kumar, and S. Kumar, “Regulation of cytochrome P450 2e1 expression by ethanol: role of oxidative stress-mediated pkc/jnk/sp1 pathway,” Cell Death and Disease, vol. 4, no. 3, p. e554, 2013. View at Publisher · View at Google Scholar · View at Scopus
  96. L. D. Gorsky, D. R. Koop, and M. J. Coon, “On the stoichiometry of the oxidase and monooxygenase reactions catalyzed by liver microsomal cytochrome P-450. Products of oxygen reduction,” The Journal of Biological Chemistry, vol. 259, no. 11, pp. 6812–6817, 1984. View at Google Scholar · View at Scopus
  97. G. Ekström and M. Ingelman-Sundberg, “Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1),” Biochemical Pharmacology, vol. 38, no. 8, pp. 1313–1319, 1989. View at Publisher · View at Google Scholar · View at Scopus
  98. D. Wu and A. I. Cederbaum, “Alcohol, oxidative stress, and free radical damage,” Alcohol Research & Health, vol. 27, no. 4, pp. 277–284, 2003. View at Google Scholar · View at Scopus
  99. F. J. Gonzalez, “Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 569, no. 1-2, pp. 101–110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. Y. Lu and A. I. Cederbaum, “CYP2E1 and oxidative liver injury by alcohol,” Free Radical Biology and Medicine, vol. 44, no. 5, pp. 723–738, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. H. K. Seitz and X.-D. Wang, “The role of cytochrome P450 2E1 in ethanol-mediated carcinogenesis,” Sub-Cellular Biochemistry, vol. 67, pp. 131–143, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. D. Wu and A. I. Cederbaum, “Removal of glutathione produces apoptosis and necrosis in HepG2 cells overexpressing CYP2E1,” Alcoholism: Clinical and Experimental Research, vol. 25, no. 4, pp. 619–628, 2001. View at Publisher · View at Google Scholar · View at Scopus
  103. P. Gong and A. I. Cederbaum, “Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1,” Hepatology, vol. 43, no. 1, pp. 144–153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. A. I. Cederbaum, “Introduction—serial review: alcohol, oxidative stress and cell injury,” Free Radical Biology and Medicine, vol. 31, no. 12, pp. 1524–1526, 2001. View at Publisher · View at Google Scholar · View at Scopus
  105. F. Vaglini, C. Viaggi, V. Piro et al., “Acetaldehyde and parkinsonism: role of CYP450 2E1,” Frontiers in Behavioral Neuroscience, vol. 7, article 71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. M. Kopun and P. Propping, “The kinetics of ethanol absorption and elimination in twins and supplementary repetitive experiments in singleton subjects,” European Journal of Clinical Pharmacology, vol. 11, no. 5, pp. 337–344, 1977. View at Publisher · View at Google Scholar · View at Scopus
  107. P. M. Watts, A. G. Riedl, D. C. Douek et al., “Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase,” Neuroscience, vol. 86, no. 2, pp. 511–519, 1998. View at Publisher · View at Google Scholar · View at Scopus
  108. F. Vaglini, C. Pardini, C. Viaggi, C. Bartoli, D. Dinucci, and G. U. Corsini, “Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced mouse model of Parkinson's disease,” Journal of Neurochemistry, vol. 91, no. 2, pp. 285–298, 2004. View at Publisher · View at Google Scholar · View at Scopus
  109. C. Pardini, F. Vaglini, C. Viaggi, A. Caramelli, and G. U. Corsini, “Role of CYP2E1 in the mouse model of MPTP toxicity,” Parkinsonism and Related Disorders, vol. 14, no. 2, pp. S119–S123, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. M. A. Collins, “Tetrahydropapaveroline in Parkinson's disease and alcoholism: a look back in honor of Merton Sandler,” NeuroToxicology, vol. 25, no. 1-2, pp. 117–120, 2004. View at Publisher · View at Google Scholar · View at Scopus
  111. N. S. Ambhore, S. Antony, J. K. Mali, A. M. Kanhed, A. R. Bhalerao, and S. Bhojraj, “Pharmacological and biochemical interventions of cigarette smoke, alcohol, and sexual mating frequency on idiopathic rat model of Parkinson's disease,” Journal of Young Pharmacists, vol. 4, no. 3, pp. 177–183, 2012. View at Publisher · View at Google Scholar · View at Scopus
  112. H. Nissbrandt, F. Bergquist, J. Jonason, and G. Engberg, “Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substantia nigra: a new metabolic pathway?” Synapse, vol. 40, no. 4, pp. 294–301, 2001. View at Publisher · View at Google Scholar · View at Scopus
  113. G. U. Corsini, A. Zuddas, U. Bonuccelli, S. Schinelli, and I. J. Kopin, “1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde,” Life Sciences, vol. 40, no. 9, pp. 827–832, 1987. View at Publisher · View at Google Scholar · View at Scopus
  114. A. Zuddas, G. U. Corsini, S. Schinelli, J. N. Johannessen, U. di Porzio, and I. J. Kopin, “MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigra,” Brain Research, vol. 501, no. 1, pp. 1–10, 1989. View at Publisher · View at Google Scholar · View at Scopus
  115. F. Vaglini, F. Fascetti, D. Tedeschi, M. Cavalletti, F. Fornai, and G. U. Corsini, “Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice,” Neurodegeneration, vol. 5, no. 2, pp. 129–136, 1996. View at Publisher · View at Google Scholar · View at Scopus
  116. C. Viaggi, F. Vaglini, C. Pardini, A. Caramelli, and G. U. Corsini, “MPTP-induced model of Parkinson's disease in cytochrome P450 2E1knockout mice,” Neuropharmacology, vol. 56, no. 8, pp. 1075–1081, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. L.-Y. Zang and H. P. Misra, “Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine,” The Journal of Biological Chemistry, vol. 268, no. 22, pp. 16504–16512, 1993. View at Google Scholar · View at Scopus
  118. D. Muralikrishnan and K. P. Mohanakumar, “Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity in mice,” FASEB Journal, vol. 12, no. 10, pp. 905–912, 1998. View at Google Scholar · View at Scopus
  119. T. Obata and C. C. Chiueh, “In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP+,” Journal of Neural Transmission, vol. 89, no. 1-2, pp. 139–145, 1992. View at Publisher · View at Google Scholar · View at Scopus
  120. B. Halliwell, “Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke?” Acta Neurologica Scandinavica, Supplement, vol. 126, pp. 23–33, 1989. View at Google Scholar · View at Scopus
  121. K. Barhwal, S. K. Das, A. Kumar, S. K. Hota, and R. B. Srivastava, “Insulin receptor A and Sirtuin 1 synergistically improve learning and spatial memory following chronic salidroside treatment during hypoxia,” Journal of Neurochemistry, vol. 135, no. 2, pp. 332–346, 2015. View at Publisher · View at Google Scholar · View at Scopus
  122. K. Wirdefeldt, H.-O. Adami, P. Cole, D. Trichopoulos, and J. Mandel, “Epidemiology and etiology of Parkinson's disease: a review of the evidence,” European Journal of Epidemiology, vol. 26, no. 1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  123. N. Palacios, X. Gao, E. O'Reilly et al., “Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women,” Movement Disorders, vol. 27, no. 8, pp. 980–987, 2012. View at Publisher · View at Google Scholar · View at Scopus
  124. P. P. Rowell and M. Li, “Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors,” Journal of Neurochemistry, vol. 68, no. 5, pp. 1982–1989, 1997. View at Google Scholar · View at Scopus
  125. D. C. Perry, M. I. Dávila-García, C. A. Stockmeier, and K. J. Kellar, “Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies,” Journal of Pharmacology and Experimental Therapeutics, vol. 289, no. 3, pp. 1545–1552, 1999. View at Google Scholar · View at Scopus
  126. D. A. Di Monte, “The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?” The Lancet Neurology, vol. 2, no. 9, pp. 531–538, 2003. View at Publisher · View at Google Scholar · View at Scopus
  127. M. Singh, A. J. Khan, P. P. Shah, R. Shukla, V. K. Khanna, and D. Parmar, “Polymorphism in environment responsive genes and association with Parkinson disease,” Molecular and Cellular Biochemistry, vol. 312, no. 1-2, pp. 131–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  128. H. N. Shahabi, L. Westberg, J. Melke et al., “Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population,” Journal of Neural Transmission, vol. 116, no. 5, pp. 567–573, 2009. View at Publisher · View at Google Scholar · View at Scopus
  129. A. J. De Roos, N. Rothman, P. D. Inskip et al., “Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors,” Cancer Epidemiology Biomarkers and Prevention, vol. 12, no. 1, pp. 14–22, 2003. View at Google Scholar · View at Scopus
  130. A. M. Trescot and S. Faynboym, “A review of the role of genetic testing in pain medicine,” Pain Physician, vol. 17, no. 5, pp. 425–445, 2014. View at Google Scholar · View at Scopus
  131. O. Kaut, I. Schmitt, and U. Wüllner, “Genome-scale methylation analysis of Parkinson's disease patients' brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1,” Neurogenetics, vol. 13, no. 1, pp. 87–91, 2012. View at Publisher · View at Google Scholar · View at Scopus
  132. R. Kumsta, S. J. Marzi, J. Viana et al., “Severe psychosocial deprivation in early childhood is associated with increased DNA methylation across a region spanning the transcription start site of CYP2E1,” Translational Psychiatry, vol. 6, no. 6, article e830, 2016. View at Publisher · View at Google Scholar
  133. J. C. Ledesma, M. Miquel, M. Pascual, C. Guerri, and C. M. G. Aragon, “Induction of brain cytochrome P450 2E1 boosts the locomotor-stimulating effects of ethanol in mice,” Neuropharmacology, vol. 85, pp. 36–44, 2014. View at Publisher · View at Google Scholar · View at Scopus
  134. C. Heit, H. Dong, Y. Chen et al., “The role of CYP2E1 in alcohol metabolism and sensitivity in the central nervous system,” in Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism, vol. 67 of Subcellular Biochemistry, pp. 235–247, Springer, Berlin, Germany, 2013. View at Publisher · View at Google Scholar
  135. K. Tokuda, Y. Izumi, and C. F. Zorumski, “Locally-generated acetaldehyde is involved in ethanol-mediated LTP inhibition in the hippocampus,” Neuroscience Letters, vol. 537, pp. 40–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  136. M.-A. Bae, J.-E. Pie, and B. J. Song, “Acetaminophen induces apoptosis of C6 glioma cells by activating the c-Jun NH2-terminal protein kinase-related cell death pathway,” Molecular Pharmacology, vol. 60, no. 4, pp. 847–856, 2001. View at Google Scholar · View at Scopus
  137. Y.-S. Lee, J. Wan, B.-J. Kim, M.-A. Bae, and B. J. Song, “Ubiquitin-dependent degradation of p53 protein despite phosphorylation at its N terminus by acetaminophen,” Journal of Pharmacology and Experimental Therapeutics, vol. 317, no. 1, pp. 202–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  138. V. Vasiliou, T. L. Ziegler, P. Bludeau, D. R. Petersen, F. J. Gonzalez, and R. A. Deitrich, “CYP2E1 and catalase influence ethanol sensitivity in the central nervous system,” Pharmacogenetics and Genomics, vol. 16, no. 1, pp. 51–58, 2006. View at Publisher · View at Google Scholar · View at Scopus
  139. S. M. Zimatkin, S. P. Pronko, V. Vasiliou, F. J. Gonzalez, and R. A. Deitrich, “Enzymatic mechanisms of ethanol oxidation in the brain,” Alcoholism: Clinical and Experimental Research, vol. 30, no. 9, pp. 1500–1505, 2006. View at Publisher · View at Google Scholar · View at Scopus
  140. V. I. Skvortsova, P. A. Slominsky, M. I. Shadrina et al., “Detoxication gene polymorphism and susceptibility to sporadic motor neuron disease in Russian population,” Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova, vol. 106, no. 1, pp. 4–13, 2006. View at Google Scholar · View at Scopus
  141. Z. Amit and C. M. G. Aragon, “Catalase activity measured in rats naive to ethanol correlates with later voluntary ethanol consumption: possible evidence for a biological marker system of ethanol intake,” Psychopharmacology, vol. 95, no. 4, pp. 512–515, 1988. View at Publisher · View at Google Scholar · View at Scopus
  142. M. Correa, C. Sanchis-Segura, R. Pastor, and C. M. G. Aragon, “Ethanol intake and motor sensitization: the role of brain catalase activity in mice with different genotypes,” Physiology & Behavior, vol. 82, no. 2-3, pp. 231–240, 2004. View at Publisher · View at Google Scholar · View at Scopus
  143. E. Quertemont, “Genetic polymorphism in ethanol metabolism: acetaldehyde contribution to alcohol abuse and alcoholism,” Molecular Psychiatry, vol. 9, no. 6, pp. 570–581, 2004. View at Publisher · View at Google Scholar · View at Scopus
  144. X.-S. Deng and R. A. Deitrich, “Putative role of brain acetaldehyde in ethanol addiction,” Current Drug Abuse Reviews, vol. 1, no. 1, pp. 3–8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  145. L. Sarc, B. Wraber, and M. Lipnik-Stangelj, “Ethanol and acetaldehyde disturb TNF-alpha and IL-6 production in cultured astrocytes,” Human & Experimental Toxicology, vol. 30, no. 9, pp. 1256–1265, 2011. View at Publisher · View at Google Scholar · View at Scopus
  146. M. Correa, C. Viaggi, M. A. Escrig et al., “Ethanol intake and ethanol-induced locomotion and locomotor sensitization in Cyp2e1 knockout mice,” Pharmacogenetics and Genomics, vol. 19, no. 3, pp. 217–225, 2009. View at Publisher · View at Google Scholar · View at Scopus
  147. A. Pla, M. Pascual, and C. Guerri, “Autophagy constitutes a protective mechanism against ethanol toxicity in mouse astrocytes and neurons,” PLoS ONE, vol. 11, no. 4, Article ID e0153097, 2016. View at Publisher · View at Google Scholar
  148. Y. Lu and A. Cederbaum, “Autophagy protects against CYP2E1/chronic ethanol-induced hepatotoxicity,” Biomolecules, vol. 5, no. 4, pp. 2659–2674, 2015. View at Publisher · View at Google Scholar
  149. C. Garza-Lombó and M. E. Gonsebatt, “Mammalian target of rapamycin: its role in early neural development and in adult and aged brain function,” Frontiers in Cellular Neuroscience, vol. 10, article 157, 2016. View at Publisher · View at Google Scholar
  150. G. Chen, Z. Ke, M. Xu et al., “Autophagy is a protective response to ethanol neurotoxicity,” Autophagy, vol. 8, no. 11, pp. 1577–1589, 2012. View at Publisher · View at Google Scholar · View at Scopus
  151. A. Alimov, H. Wang, M. Liu et al., “Expression of autophagy and UPR genes in the developing brain during ethanol-sensitive and resistant periods,” Metabolic Brain Disease, vol. 28, no. 4, pp. 667–676, 2013. View at Publisher · View at Google Scholar · View at Scopus
  152. H. W. Baek, S. K. Bae, M. G. Lee, and Y. T. Sohn, “Pharmacokinetics of chlorzoxazone in rats with diabetes: induction of CYP2E1 on 6-hydroxychlorzoxazone formation,” Journal of Pharmaceutical Sciences, vol. 95, no. 11, pp. 2452–2462, 2006. View at Publisher · View at Google Scholar · View at Scopus
  153. M. Stettner, D. Steinberger, C. J. Hartmann et al., “Isoniazid-induced polyneuropathy in a tuberculosis patient—implication for individual risk stratification with genotyping?” Brain and Behavior, vol. 5, no. 8, Article ID e00326, 2015. View at Publisher · View at Google Scholar
  154. A. Crawford, S. Dalvie, S. Lewis et al., “Haplotype-based study of the association of alcohol and acetaldehyde-metabolising genes with alcohol dependence (with or without comorbid anxiety symptoms) in a Cape Mixed Ancestry population,” Metabolic Brain Disease, vol. 29, no. 2, pp. 333–340, 2014. View at Publisher · View at Google Scholar · View at Scopus